Search results
Industry Analysts Just Upgraded Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Revenue Forecasts By...
Simply Wall St. via Yahoo Finance· 1 year agoSangamo Therapeutics, Inc. (NASDAQ:SGMO) shareholders will have a reason to smile today, with the...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 weeks agoSangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript May 9, 2024 Sangamo...
Sangamo to cut jobs again with planned business overhaul
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: Sangamo Therapeutics is making deeper cuts to its business in an attempt to save cash,...
November brings new flurry of biotech layoffs
BioPharma Dive via Yahoo Finance· 7 months agoBiotechnology companies continue to contend with a challenging financial outlook, with at least four publicly traded drugmakers announcing layoffs to...
7 CRISPR Stocks With the Best Long-Term Potential
InvestorPlace via Yahoo Finance· 1 year agoCRISPR technology has the potential to revolutionize the way we approach medicine. This technology has already been used in a variety of applications,...
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
InvestorPlace via Yahoo Finance· 1 year agoFinding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a...
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
InvestorPlace via Yahoo Finance· 9 months agoRare disease stocks have a difficult task. The rarer a disease is, the less public research goes...
Beam to lay off 100 employees, seek partners in research restructuring
BioPharma Dive via Yahoo Finance· 8 months agoBeam Therapeutics, the base editing biotechnology company, on Thursday said it will lay off 100...
Intellia cleared by FDA to start Phase 3 test of gene editing treatment
BioPharma Dive via Yahoo Finance· 8 months agoIntellia Therapeutics on Wednesday said it has received a green light from the Food and Drug...
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
InvestorPlace via Yahoo Finance· 1 year agoCRISPR could revolutionize the way we treat thousands of diseases. Currently, there are about 7,000...
